BNTC - 3.631 Pre-market now at 4.18/4.20 Benitec receives U.S. Orphan Drug Designation for BB-301, its ddRNAi therapeutic for the treatment of oculopharyngeal muscular dystrophy http://stockcharts.com/c-sc/sc?s=BNTC&p=D&b=5&g=0&i=t27634878511&r=1516108003340 http://stockcharts.com/c-sc/sc?s=BNTC&p=W&b=5&g=0&i=t04296108380&r=1516108036995